We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.76%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.32B
AUM Growth
+$155M
Cap. Flow
-$100M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.3%
Holding
739
New
50
Increased
312
Reduced
249
Closed
35

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$31M
2
CL icon
Colgate-Palmolive
CL
+$20M
3
MRK icon
Merck
MRK
+$18.8M
4
GLW icon
Corning
GLW
+$18.5M
5
FFIV icon
F5
FFIV
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 25.58%
2 Technology 13.62%
3 Financials 13.2%
4 Consumer Discretionary 9.51%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DELL icon
451
Dell
DELL
$283B
$1.95M 0.04%
113,617
-24,124
-18% -$442K
LVS icon
452
Las Vegas Sands
LVS
$30.5B
$1.95M 0.04%
30,494
-72,515
-70% -$4.35M
CNQ icon
453
Canadian Natural Resources
CNQ
$96.9B
$1.94M 0.04%
137,453
-9,673
-7% -$146K
ITCI
454
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.93M 0.04%
155,000
-37,000
-19% -$429K
KDP icon
455
Keurig Dr Pepper
KDP
$40.4B
$1.92M 0.04%
21,036
+1,901
+10% +$178K
ED icon
456
Consolidated Edison
ED
$41.6B
$1.91M 0.04%
23,613
+297
+1% +$24K
SNI
457
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$1.9M 0.04%
+27,842
New +$1.96M
ROST icon
458
Ross Stores
ROST
$76.6B
$1.9M 0.04%
32,830
+25,488
+347% +$1.59M
PMC
459
DELISTED
PharMerica Corporation
PMC
$1.89M 0.04%
72,000
SRE icon
460
Sempra
SRE
$60.8B
$1.87M 0.04%
33,228
PBA icon
461
Pembina Pipeline
PBA
$29.9B
$1.86M 0.04%
56,388
+27,724
+97% +$898K
WMB icon
462
Williams Companies
WMB
$90.5B
$1.86M 0.04%
61,596
-73,347
-54% -$2.18M
KR icon
463
Kroger
KR
$34.8B
$1.85M 0.03%
79,201
+8,585
+12% +$244K
ADM icon
464
Archer Daniels Midland
ADM
$41.4B
$1.83M 0.03%
44,142
+6,668
+18% +$286K
DVA icon
465
DaVita
DVA
$15.1B
$1.81M 0.03%
28,000
-7,800
-22% -$516K
PPL
466
PPL Corp
PPL
$27.3B
$1.81M 0.03%
46,866
-7,891
-14% -$305K
APH icon
467
Amphenol
APH
$188B
$1.78M 0.03%
96,420
+16,052
+20% +$293K
FPRX
468
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$1.78M 0.03%
59,000
+27,000
+84% +$843K
EXPD icon
469
Expeditors International
EXPD
$22.9B
$1.73M 0.03%
30,693
-5,679
-16% -$313K
WY icon
470
Weyerhaeuser
WY
$17.3B
$1.73M 0.03%
51,570
+1,641
+3% +$55.2K
L icon
471
Loews
L
$24.3B
$1.73M 0.03%
36,894
+6,493
+21% +$304K
OKE icon
472
Oneok
OKE
$58.7B
$1.71M 0.03%
32,830
+14,848
+83% +$768K
BBY icon
473
Best Buy
BBY
$18B
$1.7M 0.03%
29,598
+2,255
+8% +$120K
NWL icon
474
Newell Brands
NWL
$2.16B
$1.69M 0.03%
31,520
+2,120
+7% +$107K
TSM icon
475
TSMC
TSM
$2.09T
$1.69M 0.03%
48,250

Similar funds

Candriam SCA's Q2 2017 Portfolio in Review

As of Q2 2017, Candriam SCA held 739 positions worth $5.32B, up 3% from $5.17B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Candriam SCA's Q2 2017 filing shows 50 new, 312 increased, 249 reduced and 35 closed positions. Its largest new stake was Raymond James Financial: 164,790 shares worth $8.81M. The largest sale was PepsiCo, an estimated $40.4M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q2 2017 buy was Raymond James Financial: 164,790 shares worth $8.81M.
  • Candriam SCA added most to Kellanova in Q2 2017, an estimated $31M increase.
  • Candriam SCA's biggest Q2 2017 reduction was PepsiCo, cutting an estimated $40.4M.
  • Candriam SCA fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $20.4M.
  • Candriam SCA's ten largest holdings make up 16% of its $5.32B portfolio in Q2 2017.
  • Candriam SCA opened 50 new positions and closed 35 in Q2 2017.
  • Candriam SCA's portfolio value rose 3% quarter-over-quarter to $5.32B.

Based on Candriam SCA's 13F filing for Q2 2017, filed 31 Jul 2017.